Kirn David
Director, Chief Executive Officer; Director, President and Chief Executive Officer · 4 filings · Latest: Jul 9, 2026
4D Molecular Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
FDMT | Kirn David | Director, President and Chief Executive Officer | Jul 10, 2026 | Sale | $12.03 | 15,725 | $189.2K | 884,152 | |
FDMT | Kirn David | Director, President and Chief Executive Officer | Jul 9, 2026 | Sale | $12.87 | 42,608 | $548.2K | 899,877 | |
FDMT | David Kirn | — | Jul 10, 2026 | Proposed Sale | $12.31 | 15,725 | $193.6K | — | |
FDMT | David Kirn | — | Jul 9, 2026 | Proposed Sale | $12.89 | 42,608 | $549.2K | — | |
FDMT | Kirn David | Director, President and Chief Executive Officer | Jun 22, 2026 | Sale | $10.47 | 114,746 | $1.2M | 942,485 | |
FDMT | David Kirn | — | Jun 22, 2026 | Proposed Sale | $10.42 | 114,746 | $1.2M | — | |
FDMT | Kirn David | Director, President and Chief Executive Officer | Jun 1, 2026 | Sale | $10.02 | 1,922 | $19.3K | 1,057,231 | |
FDMT | David Kirn | — | Jun 1, 2026 | Proposed Sale | $9.71 | 1,922 | $18.7K | — |